Artificial Cells Nanomedicine and Biotechnology · 2016 · 31 citations · 27 references
PharmacyImmunologyPharmaceuticsDrug DeliveryImmunology Of Infectious DiseasesNanoparticle Drug DeliveryNanomaterials For Drug DeliveryNanomedicineNanoparticle DesignTuberculosis VaccinationVaccine DeliveryVaccine PlatformsChitosanChitosan NanocarriersChitosan-based Delivery SystemsChitosan-based NanomaterialsIntranasal AdministrationIntranasal ApproachIntranasal ImmunizationNanoparticles
Introduction The early secreted antigenic target 6-kDa protein (ESAT-6) plays an important role in immune protection against Tuberculosis. Owing to its great potential to increase immune response, chitosan can be considered as a suitable biodegradable polymer for intranasal administration. Methods The physiochemical properties of the nanoparticle were measured in vitro. Two weeks after the last intranasal administration, blood samples were collected and specific IgG, IFN-gama, and IL-4 levels were measured by ELISA. Results Chitosan nanoparticles containing ESAT-6 demonstrated stronger ability to induce IFN-gama, IL-4, and IgG antibody level than the control groups. Conclusion Administration of chitosan nanoparticles can be a suitable method to induce more appropriate immune responses against low inherent immunogenic tuberculosis proteins through intranasal routs.
27
John A. Armstrong, P. D’Arcy Hart · The Journal of Experimental Medicine · 1975 · 541 citations · Full text
M Harboe, T Oettinger, Harald G. Wiker et al. · Infection and Immunity · 1996 · 462 citations · Full text